Home › Funds › PSP Research LLC › IMVT

PSP Research LLC position in IMVT

IMMUNOVANT INC · Health Care

PSP Research LLC reported holding 7,000 shares of IMVT (IMMUNOVANT INC) in its Q3 2026 13F filing — a position valued at US$236K, representing 0.16% of its reported portfolio and ranking #26 among its reported holdings. PSP Research LLC has disclosed IMVT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)7.00K sh
Reported value held$236.46K
Portfolio Weight0.16%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's IMVT position evolved

PSP Research LLC first disclosed a stake in IMVT in Q4 2025 at 20,305 shares (US$516K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 7,000 shares valued at US$236K — a reduction of -6,000 shares quarter over quarter.. Notable position changes include a 32% trim in Q2 2026 (shares fell 12% over the following quarter), a 46% trim in Q3 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 20.30K $516.15K New
Q1 2026 19.20K $476.93K Reduce
Q2 2026 13.00K $500.89K Reduce
Q3 2026 7.00K $236.46K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 40 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has PSP Research LLC held IMVT?

PSP Research LLC has disclosed IMVT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in IMVT?

As of Q3 2026, PSP Research LLC holds 7.00K shares of IMVT (IMMUNOVANT INC), valued at $236.46K, representing 0.16% of its reported portfolio and ranking #26.

Has PSP Research LLC been buying or selling IMVT?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in IMVT.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.